Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 17 studies | 27% ± 15% | |
| adipocyte | 10 studies | 32% ± 7% | |
| macrophage | 5 studies | 20% ± 3% | |
| pericyte | 5 studies | 21% ± 2% | |
| glutamatergic neuron | 4 studies | 29% ± 13% | |
| hepatic stellate cell | 3 studies | 53% ± 11% | |
| adventitial cell | 3 studies | 20% ± 5% | |
| monocyte | 3 studies | 26% ± 4% | |
| interneuron | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 5757.21 | 459 / 459 | 95% | 39.44 | 1060 / 1118 |
| lung | 100% | 6957.21 | 578 / 578 | 83% | 18.55 | 959 / 1155 |
| intestine | 94% | 2468.83 | 909 / 966 | 80% | 21.58 | 420 / 527 |
| esophagus | 82% | 2049.27 | 1186 / 1445 | 86% | 28.64 | 158 / 183 |
| bladder | 100% | 3451.52 | 21 / 21 | 67% | 16.51 | 340 / 504 |
| uterus | 99% | 4639.89 | 168 / 170 | 65% | 13.57 | 298 / 459 |
| stomach | 77% | 1736.56 | 276 / 359 | 86% | 26.48 | 247 / 286 |
| skin | 85% | 7701.62 | 1532 / 1809 | 70% | 14.67 | 331 / 472 |
| ovary | 94% | 2685.24 | 170 / 180 | 51% | 9.33 | 219 / 430 |
| pancreas | 41% | 632.18 | 133 / 328 | 95% | 45.88 | 169 / 178 |
| prostate | 92% | 2295.88 | 225 / 245 | 43% | 4.36 | 218 / 502 |
| liver | 91% | 2154.94 | 206 / 226 | 36% | 5.71 | 148 / 406 |
| adrenal gland | 94% | 2396.18 | 242 / 258 | 33% | 5.97 | 76 / 230 |
| kidney | 65% | 1450.79 | 58 / 89 | 56% | 8.62 | 504 / 901 |
| thymus | 87% | 1740.49 | 570 / 653 | 28% | 3.72 | 168 / 605 |
| adipose | 100% | 9180.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 8852.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 3687.54 | 1318 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 23.76 | 36 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 16.87 | 23 / 29 |
| heart | 75% | 2532.69 | 648 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 39% | 1217.88 | 364 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 38% | 6.01 | 30 / 80 |
| brain | 8% | 108.05 | 223 / 2642 | 11% | 1.54 | 79 / 705 |
| muscle | 10% | 146.34 | 83 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030199 | Biological process | collagen fibril organization |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0016485 | Biological process | protein processing |
| GO_0030324 | Biological process | lung development |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0030574 | Biological process | collagen catabolic process |
| GO_0043588 | Biological process | skin development |
| GO_0006508 | Biological process | proteolysis |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0004222 | Molecular function | metalloendopeptidase activity |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0008237 | Molecular function | metallopeptidase activity |
| Gene name | ADAMTS2 |
| Protein name | ADAM metallopeptidase with thrombospondin type 1 motif 2 A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI) |
| Synonyms | PCINP PCPNI |
| Description | FUNCTION: Cleaves the propeptides of type I and II collagen prior to fibril assembly (By similarity). Does not act on type III collagen (By similarity). Cleaves lysyl oxidase LOX at a site downstream of its propeptide cleavage site to produce a short LOX form with reduced collagen-binding activity . . |
| Accessions | A0A8V8TMU7 ENST00000518335.3 ENST00000698889.1 ENST00000274609.5 [O95450-2] A0A1B0GTY3 ENST00000251582.12 [O95450-1] O95450 |